Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
about
Association between lifestyle factors and plasma adiponectin levels in Japanese men.The Intricate Network of Adipokines and StrokeAlterations in mouse hypothalamic adipokine gene expression and leptin signaling following chronic spinal cord injury and with advanced ageLow plasma adiponectin levels and risk of colorectal cancer in men: a prospective studyEfficacy of antioxidant treatment in reducing resistin serum levels: a randomized studyResistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individualsInvestigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.Body fat distribution, adipocyte size, and metabolic characteristics of nondiabetic adultsRelationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk preventionResistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function.Even- and odd-chain saturated fatty acids in serum phospholipids are differentially associated with adipokinesResistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health InitiativeMetabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomAllergic contact dermatitis is associated with significant oxidative stressGenetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.Adiponectin: Probe of the molecular paradigm associating diabetes and obesity.Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice.Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index.Pharmacological effects of lipid-lowering drugs on circulating adipokines.Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo.Human resistin: found in translation from mouse to manThe association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients.Serum resistin and glomerular filtration rate in patients with type 2 diabetes.Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications.Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome.Hypoadiponectinemia in obese subjects with type II diabetes: A close association with central obesity indices.Adiponectin/leptin ratio and metabolic syndrome in a Mexican American population.Inverse Levels of Adiponectin in Type 1 and Type 2 Diabetes Are in Accordance with the State of Albuminuria.Diabetes Mellitus 2014.Association of Inflammation with Metabolic Syndrome among Low-Income Rural Kazakh and Uyghur Adults in Far Western China.Over expression of resistin in adipose tissue of the obese induces insulin resistance.Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.Hyperresistinemia - a novel feature in systemic infection during human pregnancy.Measurement of salivary resistin level in patients with type 2 diabetes.Protein quality control in the early secretory pathwayEndothelial dysfunction and arterial abnormalities in childhood obesity.
P2860
Q24812059-4DBF9AA4-31B0-4467-B987-A5A35BEC081EQ26771261-BBD9DD0A-2CEC-4EF8-9F2D-83F0CE4DF32BQ27333098-7E9718A0-6D84-4BBE-875F-13A4AC6B2770Q28193386-F7AA1620-AD72-4E51-8154-D2B13F3C267DQ28469198-99B5A51A-1B3A-4531-B196-8B81F07D31D2Q30382436-02A0F5E7-0FB4-4CE6-9A57-06969D88B970Q30841816-73F32BB4-6B53-484F-989B-C02E7AB084D1Q33380278-C472CB8D-6F13-41CE-AE9F-65BD4596B229Q33552031-DC76752A-4EFA-405B-A2CF-EE401A3A4A05Q33586678-1C243886-B729-4A30-8250-9E80B48261E8Q33627732-0153C7CF-3EFA-4147-82BC-AFDFE0A77A09Q33686101-0285D25E-8F93-4DE0-8DF2-FAF7E9F822B7Q33732047-F1A15587-BF35-4EE1-900F-F7B1AE9217FDQ33762112-1CF5B866-B16C-4E0D-81A7-199CA3797CAFQ34031701-8B580CD0-36FD-4983-B714-BFBF5A58D10BQ34072475-7B3451E5-9B0B-433F-B4C2-02BDEEF1DEEDQ34087359-ADDF9A2D-26B6-4E49-A1B4-00C853286545Q34418980-EA7C4632-715A-4F51-9A6C-3E1E119DA5A5Q34462955-A5098070-B938-45B1-AA15-B124EC7D6225Q34615398-C65B482A-3B89-431F-94E7-A380762B6AEFQ34703199-30D0E16A-0D34-460D-81D7-87BA354E4BA6Q34877922-93E0E4E4-6A3B-4287-A7A1-352B5E227A98Q34984106-C00621AA-FAE4-4684-9019-03B18632DB97Q35087560-8694CE49-481F-460E-85DA-605F3F3382AEQ35091445-67750B7C-0C99-4D89-9319-5446FF51A9EAQ35141900-2D76A85F-3708-40D6-8C65-F403C98629E4Q35219743-183E92ED-DEAB-4222-A79C-9DE812289EA1Q35239494-3CE00F88-02C0-4E15-8055-07BDD7CCF4D2Q35245193-1873A6BF-00D3-457C-A993-D0AC30DCD7CEQ35544900-11F12F46-E8ED-4BF2-ACEB-47CBB05324ACQ35668964-76843062-4BFC-4FEB-85AA-CDAB4A848263Q35671321-1D1B8153-CCA3-4C92-A5B9-9C4D336B2A82Q35691474-55382727-9655-45B9-BAE5-D2DBABB8D56DQ35851654-C6A87D54-CB8E-45DF-B67A-AD207AEA903CQ36103354-D85FF437-897E-43DA-8A17-C2530CDA5A79Q36148478-C386601B-01B0-4934-A8F5-7B3C7BEF1C67Q36185081-DD2B805A-EDF4-4556-8F7C-75DBE4EC20D8Q36219613-73359D01-90DF-4064-BD95-14C2B63F40E5Q36446833-436C5EC1-0178-4711-AE65-7273291D59FBQ36519884-DC1EE12B-0629-4B5A-8CF3-6C77AE278DF8
P2860
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Circulating adiponectin and re ...... subjects at risk for diabetes.
@en
Circulating adiponectin and re ...... subjects at risk for diabetes.
@nl
type
label
Circulating adiponectin and re ...... subjects at risk for diabetes.
@en
Circulating adiponectin and re ...... subjects at risk for diabetes.
@nl
prefLabel
Circulating adiponectin and re ...... subjects at risk for diabetes.
@en
Circulating adiponectin and re ...... subjects at risk for diabetes.
@nl
P2093
P1433
P1476
Circulating adiponectin and re ...... subjects at risk for diabetes.
@en
P2093
Aristidis Veves
Christos S Mantzoros
Edward S Horton
Greeshma K Shetty
Panayiotis A Economides
P304
P356
10.2337/DIACARE.27.10.2450
P407
P577
2004-10-01T00:00:00Z